vs
STANDARD BIOTOOLS INC.（LAB）与Ladder Capital Corp（LADR）财务数据对比。点击上方公司名可切换其他公司
Ladder Capital Corp的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$22.3M vs $19.6M），Ladder Capital Corp净利率更高（71.0% vs -177.4%，领先248.4%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -18.0%），Ladder Capital Corp自由现金流更多（$78.7M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -22.5%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Ladder Capital Corp是一家总部位于美国的领先商业地产金融机构，核心业务包括发放优先级商业抵押贷款、夹层债务，投资商业地产抵押担保证券及直接持有商业地产资产，服务覆盖美国多地的地产所有者、运营商与开发商。
LAB vs LADR — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $22.3M |
| 净利润 | $-34.7M | $15.9M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 69.5% |
| 净利率 | -177.4% | 71.0% |
| 营收同比 | -11.5% | -18.0% |
| 净利润同比 | -28.8% | -49.4% |
| 每股收益（稀释后） | $-0.09 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $22.3M | ||
| Q3 25 | $19.6M | $27.8M | ||
| Q2 25 | $21.8M | $21.5M | ||
| Q1 25 | $40.8M | $20.3M | ||
| Q4 24 | — | $27.2M | ||
| Q3 24 | $22.1M | $38.4M | ||
| Q2 24 | $22.5M | $34.3M | ||
| Q1 24 | $45.5M | $37.1M |
| Q4 25 | — | $15.9M | ||
| Q3 25 | $-34.7M | $19.2M | ||
| Q2 25 | $-33.5M | $17.1M | ||
| Q1 25 | $-26.0M | $11.6M | ||
| Q4 24 | — | $31.3M | ||
| Q3 24 | $-26.9M | $27.6M | ||
| Q2 24 | $-45.7M | $32.1M | ||
| Q1 24 | $-32.2M | $16.4M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 69.5% | ||
| Q3 25 | -168.5% | 72.4% | ||
| Q2 25 | -118.1% | 96.7% | ||
| Q1 25 | -80.8% | 52.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -120.9% | 74.1% | ||
| Q2 24 | -134.5% | 90.4% | ||
| Q1 24 | -132.2% | 49.4% |
| Q4 25 | — | 71.0% | ||
| Q3 25 | -177.4% | 69.0% | ||
| Q2 25 | -153.7% | 79.5% | ||
| Q1 25 | -63.8% | 56.8% | ||
| Q4 24 | — | 115.1% | ||
| Q3 24 | -122.0% | 71.7% | ||
| Q2 24 | -203.3% | 93.6% | ||
| Q1 24 | -70.6% | 44.2% |
| Q4 25 | — | $0.13 | ||
| Q3 25 | $-0.09 | $0.15 | ||
| Q2 25 | $-0.09 | $0.14 | ||
| Q1 25 | $-0.07 | $0.09 | ||
| Q4 24 | — | $0.25 | ||
| Q3 24 | $-0.07 | $0.22 | ||
| Q2 24 | $-0.12 | $0.26 | ||
| Q1 24 | $-0.27 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $38.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $1.5B |
| 总资产 | $539.6M | $5.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $38.0M | ||
| Q3 25 | $129.4M | $49.4M | ||
| Q2 25 | $158.6M | $134.9M | ||
| Q1 25 | $150.9M | $479.8M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $210.6M | $1.6B | ||
| Q2 24 | $269.8M | $1.2B | ||
| Q1 24 | $287.1M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $399.7M | $1.5B | ||
| Q2 25 | $424.5M | $1.5B | ||
| Q1 25 | $454.6M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $489.3M | $1.5B | ||
| Q2 24 | $510.3M | $1.5B | ||
| Q1 24 | $577.3M | $1.5B |
| Q4 25 | — | $5.2B | ||
| Q3 25 | $539.6M | $4.7B | ||
| Q2 25 | $557.0M | $4.5B | ||
| Q1 25 | $579.6M | $4.5B | ||
| Q4 24 | — | $4.8B | ||
| Q3 24 | $681.5M | $4.8B | ||
| Q2 24 | $708.7M | $4.8B | ||
| Q1 24 | $777.7M | $5.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $87.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $78.7M |
| 自由现金流率自由现金流/营收 | -118.1% | 352.4% |
| 资本支出强度资本支出/营收 | 4.5% | 37.4% |
| 现金转化率经营现金流/净利润 | — | 5.49× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $118.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $87.0M | ||
| Q3 25 | $-22.2M | $26.3M | ||
| Q2 25 | $-20.7M | $44.0M | ||
| Q1 25 | $-30.3M | $-28.7M | ||
| Q4 24 | — | $133.9M | ||
| Q3 24 | $-27.9M | $169.0M | ||
| Q2 24 | $-39.0M | $45.4M | ||
| Q1 24 | $-62.5M | $-20.4M |
| Q4 25 | — | $78.7M | ||
| Q3 25 | $-23.1M | $25.9M | ||
| Q2 25 | $-22.6M | $43.4M | ||
| Q1 25 | $-35.3M | $-29.6M | ||
| Q4 24 | — | $127.4M | ||
| Q3 24 | $-30.1M | $166.0M | ||
| Q2 24 | $-41.0M | $44.9M | ||
| Q1 24 | $-63.3M | $-21.7M |
| Q4 25 | — | 352.4% | ||
| Q3 25 | -118.1% | 93.1% | ||
| Q2 25 | -103.6% | 201.6% | ||
| Q1 25 | -86.6% | -145.6% | ||
| Q4 24 | — | 468.2% | ||
| Q3 24 | -136.4% | 432.1% | ||
| Q2 24 | -182.2% | 131.0% | ||
| Q1 24 | -138.9% | -58.6% |
| Q4 25 | — | 37.4% | ||
| Q3 25 | 4.5% | 1.7% | ||
| Q2 25 | 8.7% | 2.9% | ||
| Q1 25 | 12.4% | 4.3% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | 10.2% | 7.8% | ||
| Q2 24 | 8.6% | 1.3% | ||
| Q1 24 | 1.7% | 3.7% |
| Q4 25 | — | 5.49× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 2.57× | ||
| Q1 25 | — | -2.49× | ||
| Q4 24 | — | 4.27× | ||
| Q3 24 | — | 6.13× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | -1.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LADR
暂无分部数据
